OCT 30, 2018 8:00 AM PDT

CTS Essential 8 Medium: Transition your PSC research to the clinic with confidence

Speakers
  • Scientist, Research and Development, Cell Biology, Thermo Fisher Scientific
    Biography
      Lauren completed her BS in Biology at Virginia Tech and MS in Biotechnology at Johns Hopkins University before joining Life Technologies (now part of Thermo Fisher Scientific) in 2013 as an R&D Scientist. Her development work focuses on next generation stem cell culture systems, providing researchers efficient tools for stem cell culture, cryopreservation and differentiation. Her recent work has focused on development of cell therapy grade products enabling stem cell culture for translational and clinical research.
    • Product Manager, Cell Biology Life Sciences Solutions Group Thermo Fisher Scientific
      Biography
        Joanna Asprer has over ten years of experience as a bench scientist and six years of experience in the bioscience industry. She received her doctorate in Developmental Biology from Baylor College of Medicine in Houston, Texas, where her dissertation was on the transcriptional regulation of neuronal differentiation in the cerebral cortex and spinal cord. After a postdoctoral position studying inner ear development at Baylor College of Medicine, she obtained business training at Keck Graduate Institute. Joanna then joined Life Technologies (now a part of Thermo Fisher Scientific) as a scientist in Research and Development. There, she developed tools for the pluripotent stem cell workflow and supported product management in the commercialization of these products. For the last three years, Joanna has been a product manager with the same company, where she works with a cross-functional core team to develop, commercialize, support, and grow products in the pluripotent stem cell workflow, most prominently, PSC culture media for basic research or for cell therapies.

      Abstract:
      Register now for live event or to view the webinar on demand if you cannot make the live time.
       
      DATE:  October 30, 2018
      TIME:   8:00am PDT, 11:00am EDT
       
      Does your PSC medium support cell therapy? In this webinar, learn about Cell Therapy Systems™ (CTS™) Essential 8™ Medium, a feeder-free pluripotent stem cell (PSC) medium that has been designed to satisfy global regulatory requirements. CTS Essential 8 Medium uses the same formulation as the original research-use Essential 8 Medium as designed by the laboratory of James Thomson, but with human-and animal origin-free components. Here we describe the variety of ways in which CTS Essential 8 Medium reduces risks and facilitates regulatory filings. We also lay out other products that can support the PSC-derived cell therapy workflows along with CTS Essential 8 Medium. In the second part of the webinar, we present application data as well as data comparing the performance of CTS Essential 8 with research-use Essential 8 Medium so that you can be confident in making a seamless transition to the clinic.
       
      Learning Objectives:
      • Benefits of using CTS Essential 8 Medium for translational and clinical research
      • Differences and similarities between CTS Essential 8 Medium and research-use Essential 8 Medium
      • Reagents and applications compatible with CTS Essential 8 Medium
       
      Watch our related webinars here:

      Show Resources
      You May Also Like
      JAN 23, 2020 9:00 AM PST
      C.E. CREDITS
      JAN 23, 2020 9:00 AM PST
      DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
      SEP 05, 2019 4:00 PM CEST
      C.E. CREDITS
      SEP 05, 2019 4:00 PM CEST
      DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
      AUG 27, 2019 9:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 9:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      FEB 25, 2020 9:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      FEB 25, 2020 9:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
      MAR 03, 2020 9:00 AM JST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAR 03, 2020 9:00 AM JST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
      DEC 10, 2019 9:00 AM PST
      C.E. CREDITS
      DEC 10, 2019 9:00 AM PST
      DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
      Loading Comments...
      Show Resources